Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman(Harvard University), Nir Hacohen(Cambridge Hospital), Ryan J. Sullivan(Dana-Farber Cancer Institute), Genevieve M. Boland(Harvard University), Sangeetha M. Reddy(The University of Texas MD Anderson Cancer Center), Stacey L. Bjorgaard(Broad Institute), Keith T. Flaherty(Cancer Research Center), Carl G. de Boer(University of British Columbia), Russell W. Jenkins(Broad Institute), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Michal Barzily-Rokni(Shaare Zedek Medical Center), Paul Hoover(Broad Institute), Hans Vitzthum(Harvard University), Dennie T. Frederick(Broad Institute), Alexandra–Chloé Villani(Broad Institute), Marc R. Hammond(Harvard University), Cloud P. Paweletz(Massachusetts General Hospital), David A. Barbie(Dana-Farber Cancer Institute), David Lieb(Broad Institute), Samuel S. Freeman(Broad Institute), Jean-Pierre Eliane(Massachusetts General Hospital), Zachary A. Cooper(AstraZeneca (Singapore)), Elena V. Ivanova(Massachusetts General Hospital), Patrick H. Lizotte(Harvard University), Andrew Portell(Massachusetts General Hospital), Amir Reza Aref(Massachusetts General Hospital), Shauna Blackmon(Harvard University), Vancheswaran Gopalakrishnan(AstraZeneca (United States)), Alexandre Reuben(The University of Texas MD Anderson Cancer Center), Anat Stemmer‐Rachamimov(Massachusetts General Hospital), Bo Li(Children's Hospital of Philadelphia), Gad Getz(Broad Institute), Jonathan Chen(Broad Institute), Keren Yizhak(Broad Institute)
Cited by 2,037
Related Papers
Full-length transcriptome assembly from RNA-Seq data without a reference genome
|Nature Biotechnology|2011|22.7k
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k